Trials / Completed
CompletedNCT03035084
Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena?
Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena? A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Several studies have demonstrated that D2 treatment is associated with a decrease in 25(OH)D3 level and therefore have proposed that D3 would be preferable in term of raising total 25(OH)D level. The investigators postulate that the D2 treatment-associated decrease in 25(OH)D3 level may be related to an increase in total 25(OH)D level rather than being specific to D2 treatment, and thus there would be a D3 treatment-associated decrease in 25(OH)D2 level. The investigators plan to conduct a double-blind placebo-controlled trial to examine the effect of D3 treatment on 25(OH)D2 level and the effect of D2 treatment on 25(OH)D3 leve
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D3 | Single oral dose of 50,000 IU of vitamin D3 |
| DRUG | Vitamin D2 | Single oral dose of 50,000 IU of vitamin D2 |
| DRUG | Placebo oral capsule | Placebo oral capsule |
Timeline
- Start date
- 2017-02-15
- Primary completion
- 2017-11-20
- Completion
- 2017-11-20
- First posted
- 2017-01-27
- Last updated
- 2018-08-13
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT03035084. Inclusion in this directory is not an endorsement.